organization · Reporting owner
LILLY ENDOWMENT INC
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ELI LILLY & Co
Report date May 06, 2026 · Filed May 07, 2026
Section 16 reporting ended · disclosed 2026-05-07. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 91,881,150 |
Ending reported balance
After 2026-05-06 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-05-06 · Sale · Disposed 13,620 · Balance 91,883,358 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $995.00 to $995.9963, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) and (2) to this Form 4. Row 2 · 2026-05-06 · Sale · Disposed 2,208 · Balance 91,881,150 F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $996.00 to $996.46, inclusive. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $995.00 to $995.9963, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) and (2) to this Form 4.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $996.00 to $996.46, inclusive.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 15, 2021 Filed Dec 16, 2021 21:59 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 19,731 | $270.49 | $5,337,038.19 |
DisclosureSEC source: 0001209191-21-069987 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,797,773 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $270.0217 to $271.01, inclusive. Read SEC document |
| December 15, 2021 Filed Dec 16, 2021 21:59 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 13,222 | $269.65 | $3,565,338.74 |
DisclosureSEC source: 0001209191-21-069987 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,817,504 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $269.02 to $270.01, inclusive. Read SEC document |
| December 15, 2021 Filed Dec 16, 2021 21:59 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 8,808 | $268.41 | $2,364,120.05 |
DisclosureSEC source: 0001209191-21-069987 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,830,726 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $268.00 to $268.98, inclusive. Read SEC document |
| December 15, 2021 Filed Dec 16, 2021 21:59 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 14,076 | $267.37 | $3,763,542.35 |
DisclosureSEC source: 0001209191-21-069987 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,839,534 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $267.00 to $267.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7), (8) and (9) to this Form 4. Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 15:19 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 56 | $271.00 | $15,176.00 |
DisclosureSEC source: 0001209191-21-063054 · doc4.xml · nonDerivative · entry 6 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,853,610 Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 15:19 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 44,240 | $270.48 | $11,966,123.68 |
DisclosureSEC source: 0001209191-21-063054 · doc4.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,853,666 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $270.00 to $270.98, inclusive. Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 15:19 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 74,067 | $269.59 | $19,967,796.60 |
DisclosureSEC source: 0001209191-21-063054 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,897,906 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $269.00 to $269.99, inclusive. Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 15:19 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 16,469 | $268.34 | $4,419,357.34 |
DisclosureSEC source: 0001209191-21-063054 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,971,973 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $268.00 to $268.99, inclusive. Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 15:19 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 25,227 | $267.43 | $6,746,355.70 |
DisclosureSEC source: 0001209191-21-063054 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,988,442 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $267.00 to $267.9887, inclusive. Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 15:19 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 34,941 | $266.29 | $9,304,508.77 |
DisclosureSEC source: 0001209191-21-063054 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,013,669 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $266.00 to $266.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), and (5) to this Form 4. Read SEC document |
| October 28, 2021 Filed Oct 29, 2021 18:27 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 3,028 | $256.37 | $776,273.22 |
DisclosureSEC source: 0001209191-21-062041 · doc4.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,048,610 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $256.01 to $256.75, inclusive. Read SEC document |
| October 28, 2021 Filed Oct 29, 2021 18:27 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 8,541 | $255.38 | $2,181,166.42 |
DisclosureSEC source: 0001209191-21-062041 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,051,638 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $255.00 to $255.97, inclusive. Read SEC document |
| October 28, 2021 Filed Oct 29, 2021 18:27 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 22,959 | $254.36 | $5,839,828.28 |
DisclosureSEC source: 0001209191-21-062041 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,060,179 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $254.00 to $254.99, inclusive. Read SEC document |
| October 28, 2021 Filed Oct 29, 2021 18:27 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 41,267 | $253.66 | $10,467,869.75 |
DisclosureSEC source: 0001209191-21-062041 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,083,138 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $253.00 to $253.9975, inclusive. Read SEC document |
| October 28, 2021 Filed Oct 29, 2021 18:27 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 102,836 | $252.55 | $25,971,231.80 |
DisclosureSEC source: 0001209191-21-062041 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,124,405 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.00 to $252.995, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4) and (5) to this Form 4. Read SEC document |
| October 27, 2021 Filed Oct 28, 2021 17:13 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 21,369 | $252.33 | $5,391,997.03 |
DisclosureSEC source: 0001209191-21-061867 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,227,241 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.00 to $252.945, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| August 18, 2021 Filed Aug 19, 2021 15:35 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 15,430 | $274.31 | $4,232,603.30 |
DisclosureSEC source: 0001209191-21-052465 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,248,610 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $274.00 to $274.68, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| August 17, 2021 Filed Aug 18, 2021 17:20 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 3,060 | $274.08 | $838,697.96 |
DisclosureSEC source: 0001209191-21-052155 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,264,040 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $274.00 to $274.355, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| August 09, 2021 Filed Aug 10, 2021 19:48 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 1,300 | $272.18 | $353,830.10 |
DisclosureSEC source: 0001209191-21-050573 · doc4.xml · nonDerivative · entry 8 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,267,100 F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $271.78 to $272.76, inclusive. Read SEC document |
| August 09, 2021 Filed Aug 10, 2021 19:48 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 6,111 | $271.26 | $1,657,651.53 |
DisclosureSEC source: 0001209191-21-050573 · doc4.xml · nonDerivative · entry 7 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,268,400 F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $270.75 to $271.725, inclusive. Read SEC document |
| August 09, 2021 Filed Aug 10, 2021 19:48 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 8,323 | $270.07 | $2,247,784.29 |
DisclosureSEC source: 0001209191-21-050573 · doc4.xml · nonDerivative · entry 6 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,274,511 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $269.70 to $270.68, inclusive. Read SEC document |
| August 09, 2021 Filed Aug 10, 2021 19:48 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 6,175 | $269.08 | $1,661,550.48 |
DisclosureSEC source: 0001209191-21-050573 · doc4.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,282,834 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $268.66 to $269.65, inclusive. Read SEC document |
| August 09, 2021 Filed Aug 10, 2021 19:48 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 9,790 | $268.14 | $2,625,129.76 |
DisclosureSEC source: 0001209191-21-050573 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,289,009 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $267.645 to $268.64, inclusive. Read SEC document |
| August 09, 2021 Filed Aug 10, 2021 19:48 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 41,509 | $266.87 | $11,077,672.87 |
DisclosureSEC source: 0001209191-21-050573 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,298,799 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $266.63 to $267.56, inclusive. Read SEC document |
| August 09, 2021 Filed Aug 10, 2021 19:48 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 27,187 | $266.44 | $7,243,595.53 |
DisclosureSEC source: 0001209191-21-050573 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,340,308 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $265.63 to $266.625, inclusive. Read SEC document |
| August 09, 2021 Filed Aug 10, 2021 19:48 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 4,316 | $264.81 | $1,142,919.96 |
DisclosureSEC source: 0001209191-21-050573 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,367,495 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $264.50 to $265.34, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7), and (8) to this Form 4. Read SEC document |
| August 06, 2021 Filed Aug 9, 2021 16:58 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 7,597 | $264.05 | $2,005,965.06 |
DisclosureSEC source: 0001209191-21-050316 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,371,811 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $264.00 to $264.17, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| August 05, 2021 Filed Aug 6, 2021 16:57 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 4,644 | $265.23 | $1,231,709.54 |
DisclosureSEC source: 0001209191-21-050110 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,379,408 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $265.00 to $265.52, inclusive. Read SEC document |
| August 05, 2021 Filed Aug 6, 2021 16:57 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 128,048 | $264.23 | $33,833,610.85 |
DisclosureSEC source: 0001209191-21-050110 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,384,052 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $264.00 to $264.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| August 04, 2021 Filed Aug 5, 2021 19:52 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 300 | $269.87 | $80,960.70 |
DisclosureSEC source: 0001209191-21-049909 · doc4.xml · nonDerivative · entry 10 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,512,100 F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $269.2683 to $270.25, inclusive. Read SEC document |
| August 04, 2021 Filed Aug 5, 2021 19:52 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 679 | $268.54 | $182,340.70 |
DisclosureSEC source: 0001209191-21-049909 · doc4.xml · nonDerivative · entry 9 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,512,400 F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $268.1603 to $269.0285, inclusive. Read SEC document |
| August 04, 2021 Filed Aug 5, 2021 19:52 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 1,085 | $267.76 | $290,522.86 |
DisclosureSEC source: 0001209191-21-049909 · doc4.xml · nonDerivative · entry 8 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,513,079 F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $267.1545 to $268.1217, inclusive. Read SEC document |
| August 04, 2021 Filed Aug 5, 2021 19:52 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 2,409 | $266.70 | $642,468.26 |
DisclosureSEC source: 0001209191-21-049909 · doc4.xml · nonDerivative · entry 7 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,514,164 F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $266.147 to $267.1199, inclusive. Read SEC document |
| August 04, 2021 Filed Aug 5, 2021 19:52 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 2,430 | $265.52 | $645,213.60 |
DisclosureSEC source: 0001209191-21-049909 · doc4.xml · nonDerivative · entry 6 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,516,573 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $265.0931 to $266.0919, inclusive. Read SEC document |
| August 04, 2021 Filed Aug 5, 2021 19:52 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 2,410 | $264.53 | $637,505.25 |
DisclosureSEC source: 0001209191-21-049909 · doc4.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,519,003 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $264.0783 to $265.0472, inclusive. Read SEC document |
| August 04, 2021 Filed Aug 5, 2021 19:52 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 2,210 | $263.48 | $582,290.80 |
DisclosureSEC source: 0001209191-21-049909 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,521,413 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $263.06 to $264.0296, inclusive. Read SEC document |
| August 04, 2021 Filed Aug 5, 2021 19:52 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 1,214 | $262.74 | $318,967.57 |
DisclosureSEC source: 0001209191-21-049909 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,523,623 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $262.06 to $263.05, inclusive. Read SEC document |
| August 04, 2021 Filed Aug 5, 2021 19:52 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 352 | $261.59 | $92,079.33 |
DisclosureSEC source: 0001209191-21-049909 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,524,837 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $261.0537 to $261.8898, inclusive. Read SEC document |
| August 04, 2021 Filed Aug 5, 2021 19:52 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 369 | $260.19 | $96,010.48 |
DisclosureSEC source: 0001209191-21-049909 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,525,189 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $259.7119 to $260.59, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7), (8), (9), and (10) to this Form 4. Read SEC document |
| August 03, 2021 Filed Aug 4, 2021 19:15 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 2,079 | $258.06 | $536,502.58 |
DisclosureSEC source: 0001209191-21-049587 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,525,558 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $258.04 to $258.29, inclusive. Read SEC document |
| August 03, 2021 Filed Aug 4, 2021 19:15 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 10,075 | $257.68 | $2,596,136.08 |
DisclosureSEC source: 0001209191-21-049587 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,527,637 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $257.0099 to $258.00, inclusive. Read SEC document |
| August 03, 2021 Filed Aug 4, 2021 19:15 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 224,388 | $256.03 | $57,449,835.25 |
DisclosureSEC source: 0001209191-21-049587 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,537,712 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $256.00 to $256.73, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4. Read SEC document |
| July 21, 2021 Filed Jul 22, 2021 14:47 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 86,111 | $237.00 | $20,408,307.00 |
DisclosureSEC source: 0001209191-21-047671 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,762,100 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.00 to $237.01, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| July 20, 2021 Filed Jul 21, 2021 15:12 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 15,610 | $237.06 | $3,700,428.55 |
DisclosureSEC source: 0001209191-21-047547 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,848,211 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.00 to $237.75, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| July 14, 2021 Filed Jul 15, 2021 18:03 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 10,780 | $237.02 | $2,555,118.72 |
DisclosureSEC source: 0001209191-21-046740 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,863,821 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.00 to $237.14, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| July 12, 2021 Filed Jul 13, 2021 19:08 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 3,238 | $237.09 | $767,694.18 |
DisclosureSEC source: 0001209191-21-046471 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,874,601 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.00 to $237.325, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| July 09, 2021 Filed Jul 12, 2021 16:58 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 12,248 | $238.07 | $2,915,905.86 |
DisclosureSEC source: 0001209191-21-046268 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,877,839 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $238.00 to $238.33, inclusive. Read SEC document |
| July 09, 2021 Filed Jul 12, 2021 16:58 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 97,013 | $237.30 | $23,021,184.90 |
DisclosureSEC source: 0001209191-21-046268 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,890,087 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.00 to $237.995, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| July 06, 2021 Filed Jul 7, 2021 13:17 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 210,000 | $235.09 | $49,369,047.00 |
DisclosureSEC source: 0001209191-21-045737 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,987,100 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.00 to $235.55, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| July 02, 2021 Filed Jul 6, 2021 17:05 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 4,300 | $234.13 | $1,006,737.50 |
DisclosureSEC source: 0001209191-21-045315 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,197,100 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $234.105 to $234.22, inclusive. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.